Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.


Endothelin-1 infusion into humans to obtain pathophysiological plasma levels causes mild hypertension, strong renal vasoconstriction, and sodium retention. We studied whether oral use of the angiotensin-converting enzyme inhibitor enalapril (20 mg BID) or the calcium channel blocker nifedipine (60 mg OD) could attenuate these effects of endothelin-1 (2.5 ng… (More)


  • Presentations referencing similar topics